Three novel mutations of STK11 gene in Chinese patients with Peutz-Jeghers syndrome
Related Experiment Video
Updated: Mar 12, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Hu Tan1, Libin Mei1, Yanru Huang1
1The State Key Laboratory of Medical Genetics, Central South University, 110 Xiangya Road, Changsha, Hunan, 410078, China.
Insights
Peutz-Jeghers syndrome (PJS) is a rare inherited disorder. Genetic analysis identified new STK11 gene mutations, with truncating mutations linked to severe complications, aiding PJS patient surveillance.
Area of Science:
- Genetics
- Oncology
- Gastroenterology
Background:
- Peutz-Jeghers syndrome (PJS) is a rare autosomal dominant disorder.
- Characterized by GI hamartomatous polyps, mucocutaneous hyperpigmentation, and increased cancer risk.
- Mutations in the serine-threonine kinase 11 (STK11) gene are the primary cause.
Purpose of the Study:
- To investigate STK11 gene mutations in Chinese PJS families.
- To expand the known spectrum of STK11 mutations.
- To explore genotype-phenotype correlations in PJS.
Main Methods:
- Sanger sequencing and MLPA assay were used for STK11 mutation screening.
- Analysis was performed on blood samples from six PJS families (eight patients).
- Genotype-phenotype correlations were assessed.
Main Results:
- Six Chinese PJS families revealed three novel STK11 mutations (c.721G>C, c.645_726del82, del(exon2-5)) and three recurrent mutations (c.752G>A, c.545T>C, del(exon1)).
- Truncating STK11 mutations were associated with more severe clinical complications.
- The findings broaden the known mutation spectrum of the STK11 gene.
Conclusions:
- The study expands the STK11 mutation spectrum in PJS.
- Identifying novel and recurrent mutations aids in genetic diagnosis.
- Findings support enhanced clinical surveillance for PJS patients, particularly those with truncating mutations.
Background:
Peutz-Jeghers syndrome (PJS) is a rare autosomal dominant inherited disorder characterized by gastrointestinal (GI) hamartomatous polyps, mucocutaneous hyperpigmentation, and an increased risk of cancer. Mutations in the serine-threonine kinase 11 gene (SKT11) are the major cause of PJS.
Case Presentation:
Blood samples were collected from six PJS families including eight patients. Mutation screening of STK11 gene was performed in these six families by Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA) assay. Three novel mutations (c.721G > C, c.645_726del82, and del(exon2-5)) and three recurrent mutations (c.752G > A, c.545 T > C and del(exon1)) in STK11 were detected in six Chinese PJS families. Genotype-phenotype correlations suggested that truncating mutations trend to result in severe complications.
Conclusion:
These findings broaden the mutation spectrum of the STK11 gene and would help clinicians and genetic counselors provide better clinical surveillance for PJS patients, especially for ones carrying truncating mutation.
More Related Videos
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Single Nucleotide Polymorphisms-SNPs
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes

